Rituximab Remission Rates Similar in Mexicans as in Other Populations
Rituximab treatment led to rates of remission and relapse prevention in Mexican patients with ANCA-associated vasculitis (AAV) that were similar to those previously observed in other patient populations, a real-world study found. It was also associated with a higher rate of infections, the study found. Overall, about 65% of…